Wall Street expects a year-over-year increase in earnings on higher revenues when G-III Apparel Group (GIII) reports results for the quarter ended January 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor th
Wall Street expects a year-over-year decline in earnings on higher revenues when Vascular Biogenics (VBLT) reports results for the quarter ended December 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor tha
Global Eagle Entertainment (ENT) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the act
Wall Street expects a year-over-year increase in earnings on higher revenues when Duluth Holdings (DLTH) reports results for the quarter ended January 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that c
Wall Street expects a year-over-year increase in earnings on higher revenues when Lennar (LEN) reports results for the quarter ended February 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impa
The Children's Place (PLCE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended January 2020. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual res
IMV INC (IMV) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare
Wall Street expects a year-over-year decline in earnings on lower revenues when Actuant (EPAC) reports results for the quarter ended February 2020. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impa
Wall Street expects a year-over-year decline in earnings on lower revenues when Aptinyx Inc. (APTX) reports results for the quarter ended December 2019. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could
The market expects Translate Bio, Inc. (TBIO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2019. This widely-known consensus outlook is important in assessing the company's earnings picture, but a power
The market expects Ollie's Bargain Outlet (OLLI) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2020. This widely-known consensus outlook is important in assessing the company's earnings picture, but a po
Investors wanted to hear solutions for the current crisis. They didn’t get enough. The Dow is on pace for its worst one-day percentage decline since 1987—even after a trading halt. Coronavirus fears caused European stocks to tumble, with many indexes recording their worst one-day drop ever.
The Chemours Company CC inaugurated its innovation center, The Chemours Discovery Hub, on the University of Delaware’s Science, Technology and Advanced Research (“STAR”) campus.
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
Investors in Marathon Oil Corporation MRO need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 17, 2020 $8.00 Put had some of the highest implied volatility of all equity options today.What is Implied Volatility?Implied vo
Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.48 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to loss of $0.16 per share a year ago. These figures are adjusted for non-recurring items.
Shares of Mallinckrodt plc MNK surged almost 40% on Wednesday amid sell-off in the broader S&P 500 Index, following the support of New York State Attorney General for the company’s previously announced proposed global opioid settlement. Including New York, 48 states and te
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?One
U.S. Bancorp’s USB president and chief executive officer (CEO) Andrew Cecere received 40% hike in his total compensation package for 2019 compared with the prior year. Cecere’s total annual pay increased to $18.8 million in 2019 from $13.4 million in 2018, according to the S
Zacks
Checked
14 minutes 36 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks